Literature DB >> 3015084

Equine herpesvirus type 1 (EHV-1) induced abortions and paralysis in a Lipizzaner stud: a contribution to the classification of equine herpesviruses.

S I Chowdhury, G Kubin, H Ludwig.   

Abstract

Out of 30 cases of abortion and perinatal deaths in a Lipizzaner stud in Austria 10 mares died after having shown central nervous system disturbances, ataxias and paralysis. The etiological agent of this "abortion storm" was equine herpesvirus type 1 (EHV-1). The restriction enzyme pattern of the DNA from 5 isolates recovered from fetuses has been analyzed and compared with the known reference strains of EHV-1, -2, -4 and an Austrian vaccine strain. The DNA restriction profiles of the Lipizzaner isolates as well as of the vaccine strain could be identified as being typical of abortigenic strains with minor variations. Such variations on the molecular biological level of the DNA do not justify characterization of the strains as neuro-variants. The vaccine strain differed from other isolates investigated with 4 restriction endonucleases (Bam HI, Bgl II, EcoRI, Kpn I) which was due to a deletion in the unique short segment of the genome. The lack of similar DNA bands in two EHV-1 viruses, causing mild respiratory disease, as well as in the vaccine strain Prevaccinol is suggestive of lowered virulence. In contrast to one Lipizzaner isolate tested (strain Austria IV) the Austrian vaccine strain proved to be of strong neurovirulence for suckling mice.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3015084     DOI: 10.1007/bf01317376

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  39 in total

1.  Equine herpesvirus 1: biological and biophysical comparison of two viruses from different clinical entities.

Authors:  H C Borgen; H Ludwig
Journal:  Intervirology       Date:  1974       Impact factor: 1.763

2.  Paralysis of horses associated with equine herpesvirus 1 infection.

Authors:  T Jackson; J W Kendrick
Journal:  J Am Vet Med Assoc       Date:  1971-04-15       Impact factor: 1.936

3.  Differentiation of sub-types of equine herpesvirus I by restriction endonuclease analysis.

Authors:  M Sabine; G R Robertson; J M Whalley
Journal:  Aust Vet J       Date:  1981-03       Impact factor: 1.281

4.  Clinical report of a paralytic syndrome affecting stallions, mares and foals on a thoroughbred studfarm.

Authors:  R E Greenwood; A R Simson
Journal:  Equine Vet J       Date:  1980-07       Impact factor: 2.888

5.  Serologic and molecular comparisons of several equine herpesvirus type 1 strains.

Authors:  L W Turtinen; G P Allen; R W Darlington; J T Bryans
Journal:  Am J Vet Res       Date:  1981-12       Impact factor: 1.156

6.  Transduction of virulence in herpes simplex virus type 1 from a pathogenic to an apathogenic strain by a cloned viral DNA fragment.

Authors:  A Rösen; H Gelderblom; G Darai
Journal:  Med Microbiol Immunol       Date:  1985       Impact factor: 3.402

7.  Assessment of the base sequence homology between the two subtypes of equine herpesvirus 1.

Authors:  G P Allen; L W Turtinen
Journal:  J Virol       Date:  1982-10       Impact factor: 5.103

8.  Serological study of an outbreak of paresis due to equid herpesvirus 1 (EHV-1).

Authors:  Z Dinter; B Klingeborn
Journal:  Vet Rec       Date:  1976-07-03       Impact factor: 2.695

9.  Restriction endonuclease DNA fingerprinting of respiratory, foetal and perinatal foal isolates of equine herpesvirus type 1.

Authors:  M J Studdert
Journal:  Arch Virol       Date:  1983       Impact factor: 2.574

10.  Isolation of equine abortion virus from natural cases of equine abortion in horse kidney cell culture.

Authors:  T SHIMIZU; R ISHIZAKI; S ISHII; Y KAWAKAMI; T KAJI; K SUGIMURA; M MATUMOTO
Journal:  Jpn J Exp Med       Date:  1959-12
View more
  9 in total

1.  Equine herpes virus 1 (EHV-1) in liver, spleen, and lung as demonstrated by immunohistology and electron microscopy.

Authors:  L Jönsson; J Beck-Friis; L H Renström; T Nikkilä; P Thebo; B Sundquist
Journal:  Acta Vet Scand       Date:  1989       Impact factor: 1.695

2.  Genomic termini of equine herpesvirus 1.

Authors:  S I Chowdhury; H J Buhk; H Ludwig; W Hammerschmidt
Journal:  J Virol       Date:  1990-02       Impact factor: 5.103

3.  Safety and efficacy of a thymidine kinase negative equine herpesvirus-1 vaccine in young horses.

Authors:  J Cornick; J Martens; R Martens; R Crandell; S McConnell; S Kit
Journal:  Can J Vet Res       Date:  1990-04       Impact factor: 1.310

4.  The genomic diversity among equine herpesvirus-1 strains isolated in Japan.

Authors:  R Kirisawa; H Ohmori; H Iwai; Y Kawakami
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

5.  Major histocompatibility complex class I-restricted cytotoxic T-lymphocyte responses in horses infected with equine herpesvirus 1.

Authors:  G Allen; M Yeargan; L R Costa; R Cross
Journal:  J Virol       Date:  1995-01       Impact factor: 5.103

6.  Specificity of cleavage in replicative-form DNA of bovine herpesvirus 1.

Authors:  W Hammerschmidt; H Ludwig; H J Buhk
Journal:  J Virol       Date:  1988-04       Impact factor: 5.103

7.  Protection induced by a glycoprotein E-deleted bovine herpesvirus type 1 marker strain used either as an inactivated or live attenuated vaccine in cattle.

Authors:  Sonia Alejandra Romera; Mariana Puntel; Valeria Quattrocchi; Paula Del Médico Zajac; Patricia Zamorano; Javier Blanco Viera; Consuelo Carrillo; Shafiqul Chowdhury; Manuel V Borca; Ana M Sadir
Journal:  BMC Vet Res       Date:  2014-01-08       Impact factor: 2.741

8.  Environmental stressors may cause equine herpesvirus reactivation in captive Grévy's zebras (Equus grevyi).

Authors:  Peter A Seeber; Benoît Quintard; Florian Sicks; Martin Dehnhard; Alex D Greenwood; Mathias Franz
Journal:  PeerJ       Date:  2018-08-22       Impact factor: 2.984

9.  Equid Herpesvirus-1 Exploits the Extracellular Matrix of Mononuclear Cells to Ensure Transport to Target Cells.

Authors:  Mohamed Kamel; Selvaraj Pavulraj; Beatrix Fauler; Thorsten Mielke; Walid Azab
Journal:  iScience       Date:  2020-09-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.